Aclaris Therapeutics, Inc.

Venture-backed company · Stage unknown· Wayne, PA
Rounds on record
3
Latest round
Nov 19, 2024
Form D equity offering
Latest round size
$80.0M
Form D industry: Pharmaceuticals

Public company. Publicly listed (ACRS); its private filings are not venture rounds.

More
Ask DFX about thisView relationshipsFinancing historyInvestorsOwnership and outcomes
As of · the latest observation of this company; each round carries its own date

5 additional officers and directors

Every relationship, signal and contact on this record, with the source on each.

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

What matters now

  1. 2 investors
    named

    2 investors on record.

    The investors already on the cap table shape who leads the next round.

    Factfunding announcements, portfolio pages and Form DFor Investors, foundersInvestors →
  2. 6 directors
    board

    6 directors on record from Form D filings and board-seat attributions.

    The board is who decides on the next round and on a sale.

    FactSEC Form D related personsFor Investors, acquirersPeople →
Drawing the relationship network…

Facts

Year of incorporation
unknown
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
3
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
2

Financing history

3 rounds
  1. Nov 19, 2024
    Form D equity offering · $80.0M (form d sold) · 19 investors
    Fact Form D · “Aclaris Therapeutics, Inc. filed Form D: $79,999,999 sold of $79,999,999, Pharmaceuticals”
  2. Sep 30, 2014
    Form D equity offering · $10.6M (form d sold)
    Vivo Capital, LLC via Albert ChaSofinnova Investments, Inc. via Anand No Middle Name Mehra
    Fact Form D · “Aclaris Therapeutics, Inc. Form D, first filed 2014-10-08”
  3. Aug 30, 2012
    Form D equity offering · $20.9M (form d sold)
    Vivo Capital, LLC via Albert Cha
    Fact Form D · “Aclaris Therapeutics, Inc. Form D, first filed 2012-09-10”

Investors on record

3 edges

Ownership and outcomes

1 on record, from the private equity graph and exit reports
Outcome stated by investors

No firm portfolio page lists this company, so no outcome is stated.

Credit relationships

none on record
No lender position matched to this company.

People

5 officers, 6 directors
Show all 6 officers and directors

Timeline

1 event
  1. Dec 4, 2024
    Aclaris Therapeutics, Inc. filed Form D: $79,999,999 sold of $79,999,999, Pharmaceuticals
    Form D filed Fact Form D

Evidence

14 observations
Every observation on this company
  • Entity type: Corporation Dec 4, 2024 Fact Form D
  • Form D industry group: Pharmaceuticals Dec 4, 2024 Fact Form D
  • Amendment: false Dec 4, 2024 Fact Form D
  • Revenue range (Form D): Decline to Disclose Dec 4, 2024 Fact Form D
  • Incorporated: overFiveYears Dec 4, 2024 Fact Form D
  • Jurisdiction: Delaware Dec 4, 2024 Fact Form D
  • Amount sold (Form D): $80.0M Dec 4, 2024 Fact Form D
  • Offering amount (Form D): $80.0M Dec 4, 2024 Fact Form D
  • Exemptions: 06b Dec 4, 2024 Fact Form D
  • First sale: 2024-11-19 Dec 4, 2024 Fact Form D
  • Investors (Form D): 19 Dec 4, 2024 Fact Form D
  • Minimum investment (Form D): 0 Dec 4, 2024 Fact Form D
  • Securities offered: equity Dec 4, 2024 Fact Form D
  • Office address: Dec 4, 2024 Fact Form D

Relationships across DFX

on 1 other DFX graph
Across the graphs

Aclaris Therapeutics, Inc. is the same institution as 1 record in Private Equity.

Private Equity1

The joined record opens with the product, beside every other relationship on this page.

Checking your plan…

Record history

1 dated event on the change ledger, latest event first
  • Form D filed
    2024-12-04source on record

The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.